gliclazide has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gliclazide was administered intravenously into the right jugular vein for 12h simultaneously with the reperfusion." | 1.40 | Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats. ( Li, H; Ma, M; Tan, F; Yu, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, F | 1 |
| Li, H | 1 |
| Ma, M | 1 |
| Yu, Y | 1 |
1 other study available for gliclazide and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Topics: Animals; Apoptosis; Blood Glucose; Brain; Brain Ischemia; Disease Models, Animal; Gene Expression; G | 2014 |